Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-098552
Filing Date
2025-07-24
Accepted
2025-07-24 21:05:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 15556
  Complete submission text file 0000950170-25-098552.txt   17521
Mailing Address 9 WEST 57TH STREET 40TH FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 40TH FLOOR NEW YORK NY 10019 212-790-0000
Sculptor Capital LP (Filed by) CIK: 0001054587 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 857 702 0377
Helix Acquisition Corp. II (Subject) CIK: 0001869105 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94447 | Film No.: 251148385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)